RCEL 241220 15.00C (RCEL241220C15000) Stock Options, News & Quotes

0.15
0.000.00%

15min DelayClose Dec 20 16:00 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

19 minutes ago

NEWS

$Avita Medical (RCEL.US)$
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
Monday, 23rd December at 4:02 pm
VALENCIA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH)), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supp...

Jaguar8

Dec 19 17:46

🟢 Watchlist FRIDAY December 20,2024. N F A !

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...

Jaguar8

Dec 19 16:05

NEWS

$Avita Medical (RCEL.US)$
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
Thursday, 19th December at 5:05 pm
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDerm
Cohealyx expected to triple AVITA Medical's addressable market in burns
VALENCIA, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH)), a commercial-stage regenerative medicine company focused on first-in...

Jaguar8

May 30 08:16

NEWS

$Avita Medical (RCEL.US)$
AVITA Medical Announces FDA Approval of RECELL GO
AVITA Medical announced FDA approval for its advanced autologous cell harvesting device, RECELL GO. This next-gen device improves treatment for thermal burn wounds and full-thickness skin defects by harnessing a patient's own skin. Key advantages include faster healing, reduced pain, improved aesthetics, and fewer procedures. Enhanced features streamline the preparation of Spray-On Skin Cells and improve workflow effi...

Moomoo AI

Jan 21 15:54

Cantor Fitzgerald sees AVITA's superior growth and high gross margins as reasons for a premium. The firm also sees potential in Pacific Biosciences and AxoGen, and expects positive share price appreciation for Exagen and NeuroPace. A significant catalyst for Nyxoah's stock is anticipated with upcoming DREAM study data.

Cantor Picks RCEL as Best 2024 Medtech Idea; Bullish on PACB, AXGN, CERS